180 participants
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2025-12-12
- Completion:
- 2029-07-02
Conditions
- Squamous Non-small Cell Lung Cancer
Interventions
- BIOLOGICAL
- DRUG
- OTHER
No Results Yet